Thompson Siegel & Walmsley LLC Charles River Laboratories International, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.01 Billion
- Q2 2025
A detailed history of Thompson Siegel & Walmsley LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 40,293 shares of CRL stock, worth $7.05 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
40,293Holding current value
$7.05 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
617Shares Held
53.2MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.02 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$890 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$659 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$401 Million0.63% of portfolio
-
State Street Corp Boston, MA1.86MShares$325 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...